Clincosm LogoSign in Get a demo

EFFI-COVID-19: Efficiency of the Imaging Strategy for the Management of Suspected Covid-19

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT05077228
Collaborator
(none)
4,000
Enrollment
1
Location
12.9
Actual Duration (Months)
310.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Emergency departments have been placed at the heart of the patient triage strategy during the COVID-19 epidemic. In the absence of scientific knowledge on the most efficient strategy to put in place in emergency structures, the centers have proposed very heterogeneous protocols resulting from collaboration with local radiology and virology teams. While the pandemic in France appears to be currently under control, it is important to assess the sorting strategies put in place to deal with a new epidemic.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    4000 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Retrospective
    Official Title:
    Efficiency of the Imaging Strategy for the Management of Suspected Covid-19
    Actual Study Start Date :
    Oct 1, 2020
    Actual Primary Completion Date :
    Oct 28, 2021
    Actual Study Completion Date :
    Oct 28, 2021

    Outcome Measures

    Primary Outcome Measures

    1. A retrospective study of the imaging strategy for the management of suspected Covid-19 [Files analysed retrospectively from March 09, 2020 to May 08, 2020 will be examined]]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion criteria:

    • Major subject (≥18 years old)

    • Subject treated in the emergency rooms of participating centers for suspicion of COVID-19 presenting with fever> 38 ° and / or respiratory signs (dyspnea, cough, sputum) and / or other symptoms suggestive of COVID-19 (diarrhea , confusion ...) and / or people over 85 or living in an institution during the study period from March 9 to May 8, 2020

    • Subject affiliated to a social health insurance protection scheme

    • Subject not having expressed their opposition, after information, to the reuse of their data for the purposes of this research

    Exclusion criteria:

    • Subject having expressed opposition to participating in the study

    • Subject under guardianship or guardianship

    • Subject under safeguard of justice

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service d'accueil des urgences - Hôpitaux Universitaires de Strasbourg Strasbourg France 67091

    Sponsors and Collaborators

    • University Hospital, Strasbourg, France

    Investigators

    • Principal Investigator: Sabrina GARNIER KEPKA, MD, Service d'accueil des urgences - Hôpitaux Universitaires de Strasbourg

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Strasbourg, France
    ClinicalTrials.gov Identifier:
    NCT05077228
    Other Study ID Numbers:
    • 7976
    First Posted:
    Oct 14, 2021
    Last Update Posted:
    Nov 15, 2021
    Last Verified:
    Oct 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Strasbourg, France
    COVID-19
    SARS-COV-2
    Dyspnea
    Cough
    Sputum
    Diarrhea
    Confusion
    Additional relevant MeSH terms:
    COVID-19

    Study Results

    No Results Posted as of Nov 15, 2021